Covid-19 and alcohol associated liver disease
- PMID: 35933291
- PMCID: PMC9349236
- DOI: 10.1016/j.dld.2022.07.007
Covid-19 and alcohol associated liver disease
Abstract
The COVID-19 pandemic is having substantial impacts on the health status of individuals with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). AUD and ALD have both been impacted throughout the pandemic, with increases in alcohol use during the early stages of the pandemic, reduced access to treatment during the mid-pandemic, and challenges in managing the downstream effects in the post-COVID era. This review will focus on how the COVID-19 pandemic has impacted AUD and ALD epidemiology and access to treatment, and will discuss to address this rising AUD and ALD disease burden.
Keywords: Alcohol-associated cirrhosis; Alcohol-associated hepatitis; Alcohol-associated liver disease; COVID-19.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of interest SDL is supported in part by NIH grant T32 DK007634. AKS reports outside the submitted work personal fees from Gilead, Medscape Gastroenterology, Chronic Liver Disease Foundation, Up-to-Date, and ACG; non-financial support from AASLD and American Porphyria Foundation; and grants from NIAAA and NIDDK outside the submitted work.
References
-
- Grant B.F., Chou S.P., Saha T.D., et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the united states, 2001-2002 to 2012-2013: results from the national epidemiologic survey on alcohol and related conditions. JAMA Psychiatry. 2017;74:911–923. - PMC - PubMed
-
- Moon A.M., Yang J.Y., Barritt A.S., et al. Rising mortality from alcohol-associated liver disease in the United States in the 21st century. Am J Gastroenterol. 2020;115:79–87. - PubMed
-
- Pfefferbaum B., North C.S. Mental health and the Covid-19 pandemic. New Eng J Med. 2020;383:510–512. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
